Close

Applied DNA Sciences (APDN) Receives $3.6M in Net Proceeds from Warrant Exercise

August 9, 2022 8:15 AM EDT

Applied DNA Sciences, Inc. (NASDAQ: APDN) announced that it has received approximately $3.6 million in net proceeds following an exercise of Series B warrants by an institutional investor in the Company.

The Series B warrants exercised were issued in connection with a public offering that closed on August 8, 2022. Each Series B warrant entitles its owner to purchase one share of common stock in the Company at a per share price of $4.00 until September 8, 2023. 2.1 million Series B warrants associated with the August 8, 2022, offering remain outstanding. Series A warrants were also issued in connection with the public offering that closed on August 8, 2022. All 3.0 million Series A warrants remain outstanding until August 9, 2027.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News

Related Entities

Twitter